More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well
established that HCV is of global importance affecting all countries, leading to a major global …

BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a major cause of cirrhosis,
hepatocellular carcinoma and liver transplantation. OBJECTIVE: To estimate the burden of …

BACKGROUND: Illicit drug users account for the majority of cases of HCV infection in the
developed world, but few have received treatment. METHODS: We evaluated barriers to …

OBJECTIVE. The purpose of this study is to compare imaging-based surveillance and
diagnostic strategies in patients at risk for hepatocellular carcinoma (HCC) while taking into …

Abstract Background & Aims Despite advances in HCV treatment, recent data on treatment
uptake is sparse. HCV treatment uptake and associated factors were evaluated in a …

There are approximately 100 drugs in development to treat hepatitis C. Over the next
decade, a number of new therapies will become available. A good understanding of the cost …

Hepatitis C virus (HCV) has emerged as one of the most vexing health problems facing HIV-
infected persons. Due largely to injection drug use (IDU),> 30% of HIV-infected patients are …

Background: Globally, hepatitis C virus (HCV) infects∼ 3% of the population. The objective
of this study was to review published work and determine the direct medical costs for …

Abstract Background and Aims Supervised injection facilities (legally sanctioned spaces for
supervised consumption of illicitly obtained drugs) are controversial public health …

Background Liver diseases contribute significantly to the health and economic burden
globally. We undertook this study to assess the health system costs, out-of-pocket (OOP) …